Long-Term Outcomes in Patients With Three-Vessel Disease

CompletedOBSERVATIONAL
Enrollment

4,300

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

August 1, 2021

Study Completion Date

August 6, 2021

Conditions
Three Vessel Coronary Disease
Interventions
PROCEDURE

PCI or CABG

The PCI performed following current standard guidelines. All patients were pre-treated with aspirin and clopidogrel before catheterization. Thereafter, heparin (70-100 IU/kg) was administered before PCI, however, the use of glycoprotein IIb/IIIa inhibitors was at the physician's discretion. Dual-antiplatelet medication was administered to the patients after PCI for at least 12 months. For CABG, the left internal mammary artery was routinely used to graft to the left anterior descending artery and completed by venous grafts to other coronary branches with standard bypass techniques. The procedure was performed by surgeons experienced in on-pump or of-pump surgery at the operator's discretion.

Trial Locations (1)

116011

The First Affiliated Hospital of Dalian Medical University, Dalian

All Listed Sponsors
lead

The First Affiliated Hospital of Dalian Medical University

OTHER